UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | D | F | J | L | R | T | V | W | Y
Number of items: 17.


Boss, DS; Schwartz, GK; Middleton, MR; Amakye, DD; Swaisland, H; Midgley, RS; Ranson, M; (2010) Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. ANN ONCOL , 21 (4) 884 - 894. 10.1093/annonc/mdp377.


Dhami, P; Saffrey, P; Bruce, AW; Dillon, SC; Chiang, K; Bonhoure, N; Koch, CM; (2010) Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution. PLOS ONE , 5 (8) , Article e12339. 10.1371/journal.pone.0012339. Green open access


Fenton, TR; Gwalter, J; Cramer, R; Gout, IT; (2010) S6K1 is acetylated at lysine 516 in response to growth factor stimulation. BIOCHEM BIOPH RES CO , 398 (3) 400 - 405. 10.1016/j.bbrc.2010.06.081.

Fischer, U; Leidinger, P; Keller, A; Folarin, A; Keller, R; Graf, N; Lenhof, HP; (2010) Amplicons on chromosome 12q13-21 in glioblastoma recurrences. INT J CANCER , 126 (11) 2594 - 2602. 10.1002/ijc.24971.

Folarin, AA; Konerding, MA; Timonen, J; Nagl, S; Pedley, RB; (2010) Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography. MICROVASC RES , 80 (1) 89 - 98. 10.1016/j.mvr.2010.03.007.


jones, A; lechner, M; fourkala, E; Kristeleit, R; Widschwendter, M; (2010) Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. Epigenomics , 2 (1) 9 - 38.


Ledermann, JA; Kristeleit, RS; (2010) Optimal treatment for relapsing ovarian cancer. ANN ONCOL , 21 218 - 222. 10.1093/annonc/mdq377.


Reichold, M; Zdebik, AA; Lieberer, E; Rapedius, M; Schmidt, K; Bandulik, S; Sterner, C; (2010) KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. P NATL ACAD SCI USA , 107 (32) 14490 - 14495. 10.1073/pnas.1003072107.

Rodriguez-Acebes, S; Proctor, I; Loddo, M; Wollenschlaeger, A; Rashid, M; Falzon, M; Prevost, AT; (2010) Targeting DNA Replication before it Starts Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers. AM J PATHOL , 177 (4) 2034 - 2045. 10.2353/ajpath.2010.100421.


Taylor, RM; Wray, J; Gibson, F; (2010) Measuring quality of life in children and young people after transplantation: Methodological considerations. PEDIATR TRANSPLANT , 14 (4) 445 - 458. 10.1111/j.1399-3046.2010.01316.x.

Thirlwell, C; Will, OCC; Domingo, E; Graham, TA; McDonald, SAC; Oukrif, D; Jeffrey, R; (2010) Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas. GASTROENTEROLOGY , 138 (4) 1441 - U298. 10.1053/j.gastro.2010.01.033.

Tobias, J; Hochhauser, D; (2010) Cancer and Its Management. Wiley-Blackwell


Valle, J; Wasan, H; Palmer, DH; Cunningham, D; Anthoney, A; Maraveyas, A; Madhusudan, S; (2010) Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. NEW ENGL J MED , 362 (14) 1273 - 1281.

Vanhaesebroeck, B; Vogt, PK; Rommel, C; (2010) PI3K: From the bench to the clinic and back. Current Topics in Microbiology and Immunology , 347 (1) 1 - 19. 10.1007/82-2010-65.

Vigor, KL; Kyrtatos, PG; Minogue, S; Al-Jamal, KT; Kogelberg, H; Tolner, B; Kostarelos, K; (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. BIOMATERIALS , 31 (6) 1307 - 1315. 10.1016/j.biomaterials.2009.10.036.


Wheatley-Price, P; Blackhall, F; Lee, S-M; Ma, C; Ashcroft, L; Jitlal, M; Qian, W; (2010) The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials. In: (pp. pp. 2023-2028). OXFORD UNIV PRESS


Yap, TA; Vidal, L; Adam, J; Stephens, P; Spicer, J; Shaw, H; Ang, J; (2010) Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors. J CLIN ONCOL , 28 (25) 3965 - 3972. 10.1200/JCO.2009.26.7278.

This list was generated on Sun Oct 23 03:29:59 2016 BST.